Concepedia

Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas

Ángela Lamarca, Thomas Walter, Ivan Borbath, Patricia Freis, Bárbara Castillo Núñez, Alexa Childs, Mairéad G. McNamara, Richard Hubner, Rocio García‐Carbonero, Tim Meyer,

JNCI Journal of the National Cancer Institute · 2016 · 42 citations · 21 references

DOIFull text

Open access

Abstract

The GI-NEC score identifies two distinct patient cohorts; it provides a tool for clinicians when making treatment decisions and may be used as a stratification factor in future clinical trials.

References

21

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · New England Journal of Medicine · 2016 · 1.2K citations · Full text

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark et al. · Annals of Oncology · 2012 · 1K citations

, , +10

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

Charles G. Moertel, Larry K. Kvols, Michael J. O’Connell et al. · Cancer · 1991 · 839 citations · Full text

, , +13

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

Emmanuel Mitry, Éric Baudin, Michel Ducreux et al. · British Journal of Cancer · 1999 · 495 citations · Full text

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms

Maximilian Heetfeld, C. Chougnet, Ingrid Holst Olsen et al. · Endocrine Related Cancer · 2015 · 384 citations · Full text

, , +15